Presentations to Feature Executives from Safeguard and Select Life Sciences and Technology Partner Companies

WAYNE, Pa.--(BUSINESS WIRE)-- Safeguard Scientifics, Inc. (NYSE: SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that it will be hosting Investor Day 2012 at The Yale Club of New York City on Tuesday, October 9, 2012.

Investor Day 2012 will offer the investor community an opportunity to hear from executives from Safeguard and select partner companies about growth opportunities and value creation strategies.

INVESTOR DAY 2012 EVENT DETAILS

Date: Tuesday, October 9, 2012

Time: 8:00am 11:30am EDT

Location: The Yale Club of New York City

Speakers: SAFEGUARD SCIENTIFICS (SFE):

• Peter J. Boni , President and CEO
• Stephen T. Zarrilli , SVP and CFO
• James A. Datin , EVP and Managing Director

PARTNER COMPANY PRESENTATIONS MAY INCLUDE:

• AdvantEdge Healthcare Solutions
• Bridgevine
• Good Start Genetics
• Lumesis
• MediaMath
• NuPathe
• PixelOptics
• Putney
• ThingWorx

One-on-Ones: If you are interested in meeting one-on-one with members from Safeguards executive team or Safeguards partner companies, please contact us at (610) 975-4952 or IR@safeguard.com.

RSVP: For additional information and to RSVP, please visit our microsite at www.safeguard.com/investorday2012.

FOLLOW US

Safeguard Scientifics will be tweeting live during Investor Day 2012. Follow Safeguards StockTwits symbol $SFE for up-to-date information. You can also follow Safeguard at:

• Google+ (googleplus.safeguard.com)
• LinkedIn (linkedin.safeguard.com)
• Paper.li (paperli.safeguard.com)
• SlideShare (slideshare.safeguard.com)
• StockTwits (stocktwits.safeguard.com)
• Twitter (twitter.safeguard.com)
• YouTube (youtube.safeguard.com)

About Safeguard Scientifics

Founded in 1953 and based in Wayne, PA, Safeguard Scientifics, Inc. provides growth capital for entrepreneurial and innovative life sciences and technology companies. Safeguard targets life sciences companies in Molecular and Point-of-Care Diagnostics, Medical Devices, Regenerative Medicine, Specialty Pharmaceuticals and selected healthcare services, and technology companies in Internet / New Media, Financial Services IT, Healthcare IT and selected business services with capital requirements of up to $25 million. Safeguard participates in expansion financings, corporate spin-outs, management buyouts, recapitalizations, industry consolidations and early-stage financings. For more information, please visit our website at www.safeguard.com or our blog (blog.safeguard.com).

Safeguard Scientifics
John E. Shave , 610-975-4952
Vice President, Business Development and Corporate Communications

Source: Safeguard Scientifics

Copyright Business Wire 2012